Indivumed at the China Healthcare Summit 2026
November 2 – 4, 2026 | Shanghai, China
First-in-class begins with the target
The 13th China Healthcare Summit, presented by BioCentury and BayHelix, brings biopharma leaders, investors, and partners to Shanghai to discuss how innovation from China can compete globally. What turns it into first-in-class medicines is the choice made at the very start: which target, in which patient, with which modality.
At Indivumed, we define that Patient × Target × Modality fit from the beginning, rooted in tumor biology captured in the operating room.
Our CEO Prof. Dr. Hartmut Juhl and our CBO Dr. Matthias Evers will be in Shanghai during the summit. Let’s connect!
Panel discussion Scene Setter: First-Order Innovation in China
Our CBO Dr. Matthias Evers joins the panel “Scene Setter: First-Order Innovation in China”.
When: Tue, November 3 | 9:15 AM China Standard Time (UTC+8)
Panelists:
- Dr. Matthias Evers (Chief Business Officer, Indivumed)
- Nisa Leung (Managing Partner, Aulis Captial)
- Mike Quigley, Ph.D. (Chief Scientific Officer, Sanofi)
- Dajun Yang, M.D., Ph.D. (Chairman, Executive Director & CEO, Ascentage Pharma)
- Eric Yeung (Managing Director, Blackstone)
- Michael Yu, Ph.D. (Chairman & CEO, Innovent Biologics)
Moderator: Simone Fishburn Ph.D. (Vice President, BioCentury)